EXR
46
-2
QCOM
56
-2
FITB
53
3
JPM
69
13
NDAQ
73
2
KIM
54
17
UA
26
-4
AES
37
2
PWR
62
-8
CMA
58
2
AN
49
5
ES
40
-2
CFG
64
6
NOC
48
-3
MA
46
-9
D
48
2
PYPL
52
-6
GME
44
3
PVH
30
2
NKE
25
2
EXR
46
-2
QCOM
56
-2
FITB
53
3
JPM
69
13
NDAQ
73
2
KIM
54
17
UA
26
-4
AES
37
2
PWR
62
-8
CMA
58
2
AN
49
5
ES
40
-2
CFG
64
6
NOC
48
-3
MA
46
-9
D
48
2
PYPL
52
-6
GME
44
3
PVH
30
2
NKE
25
2
Financhill
Back

Delek US Holdings 10K Form

Sell
47

DK
Delek US Holdings

Last Price:
$21.74
Seasonality Move:
0.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DK News And Ratings

See the #1 stock for the next 7 days that we like better than DK

DK Financial Statistics

Sales & Book Value

Annual Sales: $11.9B
Cash Flow: $-202.7M
Price / Cash Flow: 3.64
Annual Sales: $2.56
Price / Book: 8.34

Profitability

EPS (TTM): -11.11000
Net Income (TTM): $-700.5M
Gross Margin: $-67.9M
Return on Equity: -88.27%
Return on Assets: -10.09%

Delek US Holdings Earnings Forecast

Key Delek US Holdings Financial Ratios

  • The Gross Profit Margin over the past 23 years for DK is -0.57%.
  • The Selling, General & Administrative Expenses for DK have been equal to 2.13% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Net Earning history of DK is -4.73% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 11 years.

Delek US Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Oil, Gas & Consumable Fuels
Sector: Energy
Current Symbol: DK
CUSIP: 24665A
Website: delekus.com

Debt

Debt-to-Equity Ratio: 19.53
Current Ratio: 0.85
Quick Ratio: 0.49

Price-to-Earnings

Trailing P/E Ratio: 54.67
Forward P/E Ratio: 0

DK Technical Analysis vs Fundamental Analysis

Sell
47
Delek US Holdings (DK) is a Sell

Is Delek US Holdings a Buy or a Sell?

  • Delek US Holdings stock is rated a Sell
    The current Delek US Holdings [DK] share price is $21.77. The Score for DK is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.